This guide provides a detailed overview of the most common side effects associated with GLP-1 drugs, why they happen, how long they last, and when they may indicate a more serious problem
Key benefits for perimenopausal women: May restore deep, slow-wave sleep stages that are commonly fragmented during hormonal transition Modulates cortisol and stress-hormone levels, addressing the elevated HPA axis activation linked to estrogen decline Animal research documents DSIP stimulates growth hormone (GH) release via hypothalamic and pituitary actions, and separately stimulates LH release via a hypothalamic site of action in estrogen-primed subjects Administration method: Subcutaneous injection, typically administered 1-3 hours before bedtime
Key Metabolic and Hormonal Factors During Perimenopause Several physiological changes converge during perimenopause, each potentially relevant to GLP-1 treatment planning
doi:10.2174/0929866053406084 Bankovi J, Andr J, Todorovi N, et al
Schell TD, Mylin LM, Georgoff I, Teresky AK, Levine AJ, Tevethia SS